Otsuka
Otsuka buys Avanir for $3.5 billion
December 3, 2014Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir
Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …
FDA accepts new schizophrenia drug filing
September 24, 2014Sales and Marketing FDA, Lundbeck, Otsuka, brexpiprazole, depression, schizophrenia
The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …
Bayer announces more changes at the top
June 6, 2014Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Dieter Weinand, Otsuka, dekkers, healthcare
US-based president at Japanese drugmaker Otsuka, Dieter Weinand, is to join Bayer Healthcare Pharmaceuticals as the new head of its …
Otsuka buys Astex for $866 million
September 6, 2013Sales and Marketing Astex, Lundbeck, Onyx, Otsuka
Otsuka Pharmaceutical is to buy UK-based Astex Pharmaceuticals in a deal that will see the Tokyo-based firm shelling out $866 …
Lundbeck/Otsuka Alzheimer’s drug improves cognition
July 17, 2013Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka
Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …
NICE thumbs-up for Abilify
June 7, 2013Sales and Marketing Abilify, BMS, NICE, Otsuka
Adolescents who suffer from bipolar disorder should be treated on the NHS with Otsuka Pharmaceuticals’ Abilify, according to draft guidance …
Lundbeck moves ahead in Q1
May 3, 2013Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1
Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …
Otsuka and UCB scale down collaboration
January 16, 2012Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB
Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …
Lundbeck and Otsuka to collaborate in CNS
November 11, 2011Research and Development, Sales and Marketing Abilify, CNS, Lundbeck, Otsuka
Lundbeck and Otsuka have signed a major collaborative deal to sell and develop up to five CNS drugs, including a …
NICE decides to back Abilify in schizophrenia
January 27, 2011Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia
NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …
Working Life: Ali Ross
September 25, 2008Medical Communications, Sales and Marketing Europe, Otsuka, communications
How did you find your way into this role?
Latest content
FibroFind appoints Lee Borthwick as CEO
